Content Section

PET for Dementia Trials

Additionally, in a National Coverage Determination for PET (FDG) for Dementia and Neurodegenerative Diseases (220.6.13) the Centers for Medicare & Medicaid Services (CMS) indicated that an FDG-PET scan is considered reasonable and necessary in patients with mild cognitive impairment or early dementia only in the context of an approved clinical trial that contains patient safeguards and protections to ensure proper administration, use and evaluation of the FDG-PET scan.

  There are 3 items in this list.

Sort by: Facility name Ascending Facility name Descending Provider Number Ascending Provider Number Descending Date approved Ascending Date approved Descending State Ascending State Descending

View Results in Excel

Facility name	Provider Number	Date approved	State
Santa Monica-UCLA Medical Center	W11817A	01/12/2007	CALIFORNIA
UCLA Medical Center	HW13029	06/07/2006	CALIFORNIA
University of Buffalo	14414A	03/12/2007	NEW YORK

View Items Per Page:102030All

Data Last Updated : 08/08/2008
Help with File Formats and Plug-Ins

Submit Feedback